These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 695

  • 1. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W, Wenzel A.
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract] [Full Text] [Related]

  • 2. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115). 1. Blood levels in dogs].
    Femmer K, Klemm W, Nürnberger H.
    Pharmazie; 1975 Oct; 30(10):673-5. PubMed ID: 694
    [No Abstract] [Full Text] [Related]

  • 3. [Study on the chronic toxicity of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane(talinolol, Cordanum, 02-115) in the rat and the beagle].
    Bartsch R, Merbt EM, Riedel H.
    Pharmazie; 1975 Oct; 30(10):659-68. PubMed ID: 691
    [No Abstract] [Full Text] [Related]

  • 4. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].
    Leonhardt U, Nürnberger H, Femmer K.
    Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690
    [No Abstract] [Full Text] [Related]

  • 5. On the pharmacokinetics of talinolol, a new beta 1-receptor blocking agent.
    Haustein KO, Fritzsche K.
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):392-5. PubMed ID: 6117520
    [Abstract] [Full Text] [Related]

  • 6. [Quantitative colorimetric determination of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert butylaminopropane (talinolol Cordanum, 02-115) in body fluids].
    Nürnberger H.
    Pharmazie; 1975 Oct; 30(10):673. PubMed ID: 693
    [No Abstract] [Full Text] [Related]

  • 7. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 8. Metabolic studies in patients with nadolol: oral and intravenous administration.
    Dreyfuss J, Brannick LJ, Vukovich RA, Shaw JM, Willard DA.
    J Clin Pharmacol; 1977 Apr; 17(5-6):300-7. PubMed ID: 16040
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).
    Goldaniga G, Montesanti L, Pianezzola E, Valzelli G.
    Eur J Drug Metab Pharmacokinet; 1980 Apr; 5(1):9-20. PubMed ID: 6104601
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 2nd communication: A single oral administration of [14C]nipradilol to spontaneously hypertensive rats.
    Kimata H, Kabuto S, Yonemitsu M, Koide T, Nakao H, Suzuki J.
    Arzneimittelforschung; 1985 Apr; 35(11):1680-4. PubMed ID: 4091870
    [Abstract] [Full Text] [Related]

  • 11. [Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].
    Regula H, Papner B.
    Arzneimittelforschung; 1974 Sep; 24(9):1328-30. PubMed ID: 4154767
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
    Wiedemann I, Peil H, Justus H, Adamus S, Brantl V, Lohmann H.
    Arzneimittelforschung; 1985 Sep; 35(6):964-9. PubMed ID: 2862877
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of betaxolol in middle aged patients.
    Bianchetti G, Thiercelin JF, Thenot JP.
    Eur J Clin Pharmacol; 1986 Sep; 31(2):231-3. PubMed ID: 2879735
    [Abstract] [Full Text] [Related]

  • 14. Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist.
    Leopold G, Pabst J, Ungethüm W, Bühring KU.
    J Clin Pharmacol; 1986 Sep; 26(8):616-21. PubMed ID: 2878941
    [Abstract] [Full Text] [Related]

  • 15. [The pharmacology of (+/-)-1-(4-cyclohexylureido-phenoxy)-2-hydroxy-3-tert-butylaminopropane (Talinolol, Cordanum, 02-115)].
    Femmer K, Bartsch R, Leonhardt U, von Littrow C, Riedel H.
    Pharmazie; 1975 Oct; 30(10):642-51. PubMed ID: 688
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G, Blatrix C, Gomeni R, Kilborn JR, Larribaud J, Lücker PW, Thebault JJ, Trocherie S, Morselli PL.
    Arzneimittelforschung; 1980 Oct; 30(11):1912-6. PubMed ID: 6109538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.